Longitudinal Study of Frailty in Shanghai Older People
1 other identifier
observational
6,000
1 country
1
Brief Summary
To investigate the prevalence of Frailty in community older residents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
August 24, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedDecember 3, 2020
May 1, 2020
4 years
August 24, 2020
November 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The level of frailty
1. Unexpected significant weight loss(\>5%). 2. Decreased strength: male grip strength ≤25 kg and female grip strength ≤18 kg 3. Reduced physical activity in the last month. 4. Slow walking speed is less than or equal to 0.8 m/s. 5. How tired you feel for the last month? The frailty period was defined as ≥3 items, early frailty was defined as 1-2 items, and non-frailty was defined as 0 items.
baseline
Secondary Outcomes (5)
Clock Drawing Test
baseline
Mini-Mental State Examination (MMSE)
baseline
Skeletal muscle mass index (SMI)
baseline
Markers of frailty
baseline
Routine inspection
baseline
Eligibility Criteria
Cluster random sampling was used in urban and rural areas of Shanghai
You may qualify if:
- more than 65 years old
- Permanent residence in Shanghai and long-term residence in the community implemented by this project (more than five years)
- Be willing to and be able to join in the study and signed Informed consent.
You may not qualify if:
- Excluding the patients whose physical function is affected by diseases or disabilities such as stroke, Parkinson's disease, tumor, fracture, etc.
- Excluding schizophrenia, depression, anxiety and other mental diseases and dependent on drug control.
- If they were unable to complete the study survey.
- Unwilling to join in the study and don't sign Informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Geriatric Institute of Chinese Medicine
Shanghai, Shanghai Municipality, 200000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chuan Chen
Shanghai Geriatric Institute of Chinese Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2020
First Posted
December 3, 2020
Study Start
January 1, 2018
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
December 3, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share